Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Minority Interest (2023 - 2024)

Historic Minority Interest for Artiva Biotherapeutics (ARTV) over the last 2 years, with Q2 2024 value amounting to $119.6 million.

  • Artiva Biotherapeutics' Minority Interest changed N/A to $119.6 million in Q2 2024 from the same period last year, while for Jun 2024 it was $119.6 million, marking a year-over-year change of. This contributed to the annual value of $119.6 million for FY2023, which is N/A changed from last year.
  • Per Artiva Biotherapeutics' latest filing, its Minority Interest stood at $119.6 million for Q2 2024.
  • Over the past 5 years, Artiva Biotherapeutics' Minority Interest peaked at $119.6 million during Q4 2023, and registered a low of $119.6 million during Q4 2023.